CD8A and cancer: Research also shows that BCG therapy induces inflammatory responses involving various immune cell subsets that eliminate cancer cells either through direct cytotoxicity or the secretion of toxic compounds, such as the tumor necrosis factor-inducing ligand.35 The immune subsets include CD4+ and CD8+ lymphocytes, natural killer cells, granulocytes, macrophages, and dendritic cells.